HAYA Therapeutics
PrivateLast Round
Series A
May 8, 2025
Total Funding Raised
$91.66M
Company Overview
HAYA Therapeutics is a biotechnology company developing programmable therapeutics targeting regulatory RNAs to reprogram pathological cell states for a broad range of diseases, including cardiovascular and metabolic diseases and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HAYA Therapeutics Comps
Public and private peers based on sector, stage, and business model.
HAYA Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 8, 2025 | ||||
| Grant | Feb 12, 2025 | ||||
| Seed | Feb 9, 2022 | ||||
| Seed | May 20, 2021 | ||||
| Grant | Feb 2, 2018 | ||||
Grant | Nov 16, 2017 |
Key People
Founding team and executive leadership
HAYA Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LifeLink Ventures | Series A |
| 4see ventures | Seed, Series A |
| +ND Capital | Series A |
| Viva BioInnovator | Seed |
| +ND Capital Fund (f.k.a. NanoDimension) | Series A |
| Humboldt Fund | Seed |
| Viva Biotech | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2025
Lead program HTX-001 advancing for hypertrophic cardiomyopathy treatment.
- Oct 1, 2025
Received the Innosuisse Certificate for Sustainable Growth.
HAYA Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about HAYA Therapeutics's valuation, stock price, and market status.
